Awakn Life Sciences Corp

Company Profile

Awakn Life Sciences Corp had its IPO on under the ticker symbol AWKNF.

The company operates in the Healthcare sector and Biotechnology industry. Awakn Life Sciences Corp has a staff strength of 44 employees.

Stock update

Shares of Awakn Life Sciences Corp opened at $0.18 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.18 - $0.22, and closed at $0.22.

This is a +18.92% increase from the previous day's closing price.

A total volume of 6,305 shares were traded at the close of the day’s session.

In the last one week, shares of Awakn Life Sciences Corp have increased by +26.66%.

Awakn Life Sciences Corp's Key Ratios

Awakn Life Sciences Corp has a market cap of $7.25 million, indicating a price to book ratio of 4.1918 and a price to sales ratio of 7.96.

In the last 12-months Awakn Life Sciences Corp’s revenue was $1.50 million with a gross profit of $-276833 and an EBITDA of $-8795078. The EBITDA ratio measures Awakn Life Sciences Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Awakn Life Sciences Corp’s operating margin was -614.69% while its return on assets stood at -101.95% with a return of equity of -649.29%.

In Q0.33333333333333, Awakn Life Sciences Corp’s quarterly earnings growth was a positive 0% while revenue growth was a positive 130.9%.

Awakn Life Sciences Corp’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.3 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Awakn Life Sciences Corp’s profitability.

Awakn Life Sciences Corp stock is trading at a EV to sales ratio of 7.9334 and a EV to EBITDA ratio of -0.5593. Its price to sales ratio in the trailing 12-months stood at 7.96.

Awakn Life Sciences Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$4.39 million

Total Liabilities

$2.46 million

Operating Cash Flow

$0

Capital Expenditure

$0

Dividend Payout Ratio

0%

Awakn Life Sciences Corp ended 2024 with $4.39 million in total assets and $0 in total liabilities. Its intangible assets were valued at $4.39 million while shareholder equity stood at $847738.00.

Awakn Life Sciences Corp ended 2024 with $0 in deferred long-term liabilities, $2.46 million in other current liabilities, in common stock, $-25953586.00 in retained earnings and $0.00 in goodwill. Its cash balance stood at $550866.00 and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $680523.00.

Awakn Life Sciences Corp’s total current assets stands at $975239.00 while long-term investments were $0 and short-term investments were $0. Its net receivables were $44109.00 compared to accounts payable of $0 and inventory worth $0.

In 2024, Awakn Life Sciences Corp's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Awakn Life Sciences Corp paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.22

52-Week High

$0.8809

52-Week Low

$0.168

Analyst Target Price

$

Awakn Life Sciences Corp stock is currently trading at $0.22 per share. It touched a 52-week high of $0.8809 and a 52-week low of $0.8809. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.18 and 200-day moving average was $0.24 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 191.9% of the company’s stock are held by insiders while 834.6% are held by institutions.